UTHealth's Arthur Day, M.D., honored by neurosurgical association

December 13, 2013

Arthur L. Day, M.D., professor of neurosurgery at The University of Texas Health Science Center at Houston (UTHealth) and a neurosurgeon at the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center, has received one of the top honors awarded by the Congress of Neurological Surgeons.

At the association's annual meeting in San Francisco Oct. 19-23, Day was presented the Founders' Laurel Award in recognition of his exceptional service, lifelong dedication and meritorious accomplishments in the field of medical education.

Day is recognized internationally for his expertise in cerebrovascular and skull base neurosurgery and directs the neurosurgery residency training program at the UTHealth Medical School. The program trains doctors focusing on the care of conditions tied to the central nervous system.

He is a past president of the association dedicated to advancing neurosurgery by providing members with educational and career development opportunities. Day has also served as chairman of the American Board of Neurological Surgery and recently concluded his presidency of the Society of Neurological Surgeons.

Day also treats people with tumors in a pea-sized organ at the base of the brain called the pituitary gland, which manages the body's production of hormones. While the majority of these tumors are benign, they can lead to problems including headaches, nausea and vision problems. It has been estimated that up to 20 percent of people have pituitary tumors but these tumors typically don't cause any problems.

He leads The Pituitary Tumor and Vision Change Clinic that is affiliated with Mischer Neuroscience Associates at Memorial Hermann-TMC. Offering less invasive tumor removal, the clinic's doctors can sometimes remove tumors with the aid of a flexible medical device (an endoscope) inserted through a patient's nose. Other treatment options include surgery, chemotherapy and radiation. The information number is 713-704-7100.

He received his medical degree from Louisiana State University School of Medicine in New Orleans. He completed a neurological surgery residency and a brain tumor immunology/neuropathology fellowship at The University of Florida at Gainesville.
-end-


University of Texas Health Science Center at Houston

Related Tumors Articles from Brightsurf:

A viable vaccine for tough tumors
While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment.

Women could conceive after ovarian tumors
Women receiving fertility-sparing surgery for treatment of borderline ovarian tumours were able to have children, a study from Karolinska Institutet in Sweden published in Fertility & Sterility shows.

Attacking tumors from the inside
A new technology that allows researchers to peer inside malignant tumors shows that two experimental drugs can normalize aberrant blood vessels, oxygenation, and other aspects of the tumor microenvironment in non-small cell lung cancer (NSCLC), helping to suppress the tumor's growth and spread, UT Southwestern researchers report.

Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.

A solid vaccine for liquid tumors
Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years.

Evolutionarily novel genes work in tumors
A team of scientists from Peter the Great St. Petersburg Polytechnic University studied the evolutionary ages of human genes and identified a new class of them expressed in tumors -- tumor specifically expressed, evolutionarily novel (TSEEN) genes.

Identification of all types of germ cells tumors
Germ cell tumors were considered very heterogeneous and diverse, until recently.

Laser light detects tumors
A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light.

Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, deciding a course of treatment can depend on a variety of factors, some of which may seem to contradict one another.

The evolution of brain tumors
Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas.

Read More: Tumors News and Tumors Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.